Recombinant Human GH Protein，His

The research on growth hormone (GH) recombinant proteins has gained significant traction in recent decades due to their crucial role in various physiological processes and therapeutic applications. Growth hormone, a peptide hormone produced by the pituitary gland, is essential for growth, metabolism, and body composition regulation. Disorders related to GH deficiency can lead to short stature and metabolic issues in children and adults. Traditionally, GH was extracted from human cadavers, raising concerns about safety and availability. The advent of recombinant DNA technology revolutionized GH production by enabling the synthesis of biosynthetic GH in bacterial, yeast, and mammalian systems. This method ensures a reliable, safe, and scalable source of GH while mitigating the risk of disease transmission. Research has focused on optimizing expression systems, enhancing yields, characterizing the biochemical properties of recombinant GH, and exploring its potential in treating conditions like GH deficiency, Turner syndrome, and muscle-wasting diseases. Furthermore, the development of modified GH variants with improved pharmacokinetics and reduced immunogenicity represents a significant advancement in therapeutic strategies. The increasing understanding of GH's multifaceted roles in endocrinology and metabolism continues to drive innovative research, ultimately aiming to improve patient outcomes and expand the applications of GH in clinical settings.